ArticleBioengineered2018

In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate.

Sina Arabshahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.